DZAU VICTOR J 4
4 · UNITED THERAPEUTICS Corp · Filed Jul 23, 2026
Research Summary
AI-generated summary of this filing
United Therapeutics (UTHR) Director Victor J. Dzau Receives Award
What Happened
Victor J. Dzau, a newly appointed director of United Therapeutics Corporation, received equity awards on July 22, 2026: 730 restricted stock units (RSUs) and 2,300 stock options. The Form 4 records these as acquisition-type derivative transactions at $0.00 per share (awards/compensation), so no cash was paid by the insider.
Key Details
- Transaction date: July 22, 2026; Form 4 filed July 23, 2026 (timely filing).
- Awards reported: 730 RSUs and 2,300 stock options (recorded as derivative securities). Acquisition price shown: $0.00.
- Shares owned after transaction: not specified in the filing.
- Footnotes:
- F1: Each RSU converts to one share of common stock upon vesting.
- F2: Awards reflect (a) initial grant on joining the Board (380 RSUs + 1,190 options) and (b) pro‑rata grants for the remainder of the 2026–2027 board year (350 RSUs + 1,110 options). Each award becomes fully vested on the one‑year anniversary of the grant date.
- F3: Restricted stock units do not have an expiration date.
- Transaction code: A = Award/Grant (compensation).
Context
These awards are compensation for Dr. Dzau’s board service, not open‑market purchases or sales. RSUs represent a right to receive shares after vesting; options are rights to buy stock subject to the option terms (exercise price and expiration not specified in the Form 4 summary provided). Because the awards vest on a one‑year schedule, they do not result in immediate share ownership until vesting occurs.
Insider Transaction Report
- Award
Restricted Stock Unit
[F1][F2][F3]2026-07-22+730→ 730 totalExercise: $0.00From: 2027-07-22→ Common Stock (730 underlying) - Award
Stock Option
[F2]2026-07-22+2,300→ 2,300 totalExercise: $527.07From: 2027-07-22Exp: 2033-07-22→ Common Stock (2,300 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
- [F2]In connection with Dr. Dzau's appointment to the Board of Directors on July 22, 2026, he was awarded restricted stock units and stock options in accordance with the Non-Employee Director Compensation Program, as follows: (a) 380 restricted stock units and 1,190 stock options, representing his initial grant upon joining the Board, and (b) 350 restricted stock units and 1,110 stock options, which are pro-rata grants representing the remainder of the 2026-2027 Board service year. Each award becomes fully vests on the one-year anniversary of the grant date.
- [F3]Not applicable as restricted stock units do not have an expiration date.